home / stock / tbgnf / tbgnf quote
Last: | $0.17 |
---|---|
Change Percent: | 0.0% |
Open: | $0.17 |
Close: | $0.17 |
High: | $0.17 |
Low: | $0.17 |
Volume: | 2,500 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.17 | $0.17 | $0.17 | $0.17 | $0.17 | 2,500 | 09-14-2022 |
$0.293 | $0.293 | $0.293 | $0.293 | $0.293 | 1,000 | 08-12-2022 |
$2 | $2 | $2 | $2 | $2 | 1,000 | 01-05-2022 |
$2.01 | $2.01 | $2.01 | $2.01 | $2.01 | 1,000 | 12-06-2021 |
$2.61 | $2.61 | $2.61 | $2.61 | $2.61 | 500 | 09-09-2021 |
$2.61 | $2.61 | $2.61 | $2.61 | $2.61 | 100 | 07-29-2021 |
$2.94 | $2.94 | $2.94 | $2.94 | $2.94 | 800 | 04-15-2021 |
$2.75 | $2.75 | $2.75 | $2.75 | $2.75 | 100 | 03-09-2021 |
$2.7885 | $3.14 | $2.7885 | $3.14 | $2.7885 | 3,500 | 02-23-2021 |
$3 | $3 | $3 | $3 | $3 | 12,500 | 12-29-2020 |
$3 | $3 | $3 | $3 | $3 | 3,500 | 12-28-2020 |
$3.35 | $3.35 | $3.35 | $3.35 | $3.35 | 14,800 | 12-25-2020 |
$3.35 | $3.35 | $3.35 | $3.35 | $3.35 | 14,800 | 12-24-2020 |
$3.35 | $3.35 | $3.35 | $3.35 | $3.35 | 4,700 | 12-23-2020 |
$3.21 | $3.21 | $3.21 | $3.21 | $3.21 | 100 | 12-21-2020 |
$3.21 | $3.21 | $3.21 | $3.21 | $3.21 | 100 | 12-08-2020 |
$3.21 | $3.21 | $3.21 | $3.21 | $3.21 | 100 | 12-01-2020 |
$2.66 | $2.66 | $2.66 | $2.66 | $2.66 | 219 | 09-24-2020 |
$3.35 | $3.35 | $3.35 | $3.35 | $3.35 | 340 | 07-20-2020 |
$3.65 | $3.65 | $3.65 | $3.65 | $3.65 | 100 | 06-23-2020 |
News, Short Squeeze, Breakout and More Instantly...
Publication Annual Report – Annual Shareholders' Meeting Leuven, BELGIUM – April 15, 2024 – 05:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, has today published its annual report for the financial year 2023. The...
Oxurion Receives EUR 450,000 in the framework of the Atlas Funding Program Eleventh tranche fully issued and paid-up Leuven, BELGIUM, 10 April 2024 – 07.00 PM CET – Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company based in Leuven, today communicates ...
Postponement Annual Shareholders Meeting - Amendment financial calendar Leuven, BELGIUM – April 5, 2024 – 02:00 PM CET Oxurion NV (Euronext Brussels: OXUR), a biopharmaceutical company headquartered in Leuven, today made the following announcement regarding its financial c...